Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Cash from Investing Activities: 2011-2024

Historic Cash from Investing Activities for Ptc Therapeutics (PTCT) over the last 14 years, with Dec 2024 value amounting to $44.2 million.

  • Ptc Therapeutics' Cash from Investing Activities fell 578.67% to -$289.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$628.3 million, marking a year-over-year decrease of 97.60%. This contributed to the annual value of $44.2 million for FY2024, which is 125.00% up from last year.
  • Per Ptc Therapeutics' latest filing, its Cash from Investing Activities stood at $44.2 million for FY2024, which was up 125.00% from -$176.7 million recorded in FY2023.
  • Ptc Therapeutics' Cash from Investing Activities' 5-year high stood at $290.2 million during FY2022, with a 5-year trough of -$561.5 million in FY2020.
  • In the last 3 years, Ptc Therapeutics' Cash from Investing Activities had a median value of $44.2 million in 2024 and averaged $52.5 million.
  • Per our database at Business Quant, Ptc Therapeutics' Cash from Investing Activities spiked by 139.03% in 2021 and then slumped by 160.91% in 2023.
  • Over the past 5 years, Ptc Therapeutics' Cash from Investing Activities (Yearly) stood at -$561.5 million in 2020, then surged by 139.03% to $219.2 million in 2021, then spiked by 32.39% to $290.2 million in 2022, then slumped by 160.91% to -$176.7 million in 2023, then soared by 125.00% to $44.2 million in 2024.